.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Analyze global market entry opportunities
  • Identify first generic entrants

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

US Department of Justice
Boehringer Ingelheim
Fish and Richardson
Julphar
Covington
AstraZeneca
Federal Trade Commission
Accenture
Moodys
Farmers Insurance

Generated: July 26, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 022556

« Back to Dashboard
NDA 022556 describes KARBINAL ER, which is a drug marketed by Tris Pharma Inc and is included in one NDA. It is available from one supplier. There are two patents protecting this drug. Additional details are available on the KARBINAL ER profile page.

The generic ingredient in KARBINAL ER is carbinoxamine maleate. There are seven drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the carbinoxamine maleate profile page.

Summary for NDA: 022556

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Formulation / Manufacturing:see details

Pharmacology for NDA: 022556

Suppliers and Packaging for NDA: 022556

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
KARBINAL ER
carbinoxamine maleate
SUSPENSION, EXTENDED RELEASE;ORAL 022556 NDA Avadel Pharmaceuticals (USA), Inc. 13551-101 13551-101-01 2 BOTTLE, PLASTIC in 1 CARTON (13551-101-01) > 30 mL in 1 BOTTLE, PLASTIC
KARBINAL ER
carbinoxamine maleate
SUSPENSION, EXTENDED RELEASE;ORAL 022556 NDA Avadel Pharmaceuticals (USA), Inc. 13551-101 13551-101-05 480 mL in 1 BOTTLE, PLASTIC (13551-101-05)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:SUSPENSION, EXTENDED RELEASE;ORALStrength4MG/5ML
Approval Date:Mar 28, 2013TE:RLD:Yes
Patent:► SubscribePatent Expiration:Mar 29, 2029Product Flag?YSubstance Flag?Delist Request?
Patent:► SubscribePatent Expiration:Jun 15, 2027Product Flag?YSubstance Flag?Delist Request?


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Covington
Merck
Chubb
QuintilesIMS
Federal Trade Commission
Daiichi Sankyo
Citi
Dow
Cerilliant
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot